Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-10-2022 | Tirofiban | Case report

Aspirin/tirofiban

Bleeding: case report

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Hu X, et al. Effect of GP IIb/IIIa inhibitor duration on the clinical prognosis of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction with no-/slow-reflow phenomenon. Biomedicine and Pharmacotherapy 143: Nov 2021. Available from: URL: http://doi.org/10.1016/j.biopha.2021.112196 Hu X, et al. Effect of GP IIb/IIIa inhibitor duration on the clinical prognosis of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction with no-/slow-reflow phenomenon. Biomedicine and Pharmacotherapy 143: Nov 2021. Available from: URL: http://​doi.​org/​10.​1016/​j.​biopha.​2021.​112196
Metadata
Title
Aspirin/tirofiban
Bleeding: case report
Publication date
01-10-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-26363-5

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Prednisolone

Case report

Multiple drugs

Case report

Aripiprazole